Why partner with AstraZeneca?
We have a global commercial presence and strength in emerging markets, particularly in China. Our innovative medicines, many of which are developed in partnership with others, are used by millions of patients worldwide.
$26.6bn
Total Revenue
$727m
Collaboration Revenue
120+
major or strategically important deals completed in last three years
800+
collaborations worldwide help us access the best science, stimulate innovation and accelerate delivery of new medicines for unmet medical needs
71,600
employees
26
manufacturing sites in 16 countries
Nearly $6bn
invested in R&D
90%
of pipeline has a precision medicine approach
For year ending 31 December 2020
Pushing the boundaries of science to deliver life-changing medicines
Inspired by our values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.
Scientific capabilities
Our range of scientific capabilities spans biologics and small molecules, as well as new drug modalities. We are looking for new and emerging drug platforms that can revolutionise the treatment of diseases. Examples are in vivo expressed biologics, novel bispecific antibodies, and nanobots/smart drug-delivery systems.
Genomic and data science
We are also harnessing the growing potential of genomic and data science to increase our understanding of disease at the molecular level. This is opening the way to pursuing the next wave of disruptive R&D platforms with new scientific modalities such as ProTACs and cell therapies; new technologies, such as OMICs; and new biology, such as epigenetics, oligonucleotides and antibody drug conjugates.
Encouraging innovation and inspiring the next generation of start-ups
Innovation in life sciences
Entrepreneurial thinking is one of our core values and at the heart of what we do. We are also passionate about supporting innovation in life sciences and helping the next generation of entrepreneurs succeed within our local bioscience ecosystems globally.
Business mentoring initiatives
Globally we have several business mentoring initiatives to support life-science entrepreneurs. More than 170 AstraZeneca employees share their scientific and business expertise with the next generation of biotech start-ups. This includes programmes run by universities, start-up accelerators and incubators, as well as investors and entrepreneurs.
Health Innovation Hubs - A.Catalyst Network
A.Catalyst Network includes more than 20 AstraZeneca global health innovation hubs, bringing together digital, R&D and commercial resources to reimagine how we can improve patient outcomes. It encourages connected decision making, collaboration, knowledge sharing, research and development, commercialisation and fostering of innovative technologies.
Veeva ID: Z4-32948
Date of Prep: May 2021